Rising Anxiety Disorders Drive Growth in the Benzodiazepine APIs Market
The global benzodiazepine APIs market is experiencing steady growth due to the increasing prevalence of anxiety disorders, insomnia, seizures, and other neurological conditions worldwide. The market was valued at US$ 472.8 Mn in 2022 and is projected to surpass US$ 652.8 Mn by 2031, expanding at a CAGR of 3.6% from 2023 to 2031. Growing awareness of mental health issues, rising healthcare...
0 Yorumlar 0 hisse senetleri 54 Views 0 önizleme